Browse bills from the 119th Congress
Browse active senators & representatives
Browse congressional committees & membership
Browse directives from the President
Cabinet members and appointees
Federal rules and proposed rules
Browse federal agencies
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Browse 1 rules and proposed rules from the Federal Register.
1
Total Regulations
Showing 1–1 of 1
The Food and Drug Administration (FDA, Agency, or we) is classifying the coagulation system for the measurement of whole blood viscoelastic properties in perioperative patients into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the coagulation system for the measurement of whole blood viscoelastic properties in perioperative patients' classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.